Shades for Migraine Partners with Rising Influencers to Empower People with Migraine
25 mai 2021 09h03 HE
|
Association of Migraine Disorders
Rhode Island, May 25, 2021 (GLOBE NEWSWIRE) -- Providence, R.I. (May 25, 2021) – Global awareness campaign, Shades for Migraine®, teams up with two rising social media influencers, YouTuber,...
Qualigen Therapeutics, Inc. Promotes Shishir Sinha to Chief Operating Officer Position
09 mars 2021 08h30 HE
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and...
Connectyx Announces Grant of License from National Institutes of Health for Use of Novel Monoclonal Antibody to Treat Glioblastoma
16 oct. 2020 11h00 HE
|
Connectyx Technologies Holdings Group, Inc
Boca Raton, FL, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel...
CYTOVIA Therapeutics and MACROMOLTEK to Develop Dual-Acting Natural Killer Immunotherapy Against SARS CoV2 (COVID-19)
07 avr. 2020 09h03 HE
|
Cytovia Therapeutics
NEW YORK and AUSTIN, Texas, April 07, 2020 (GLOBE NEWSWIRE) -- Cytovia Therapeutics (“Cytovia”), an emerging biopharmaceutical company developing Natural Killer (NK) immunotherapies for cancer and...
Natural Health Farm Holdings, Inc. and BioDelta Terminate Acquisition Agreement
14 mai 2019 19h43 HE
|
NATURAL HEALTH FARM HOLDINGS INC
Vegas, Nevada, May 14, 2019 (GLOBE NEWSWIRE) -- Natural Health Farm Holdings, Inc (OTCQB: NHEL) (the “Company” or “NHF Holdings”), a nutraceutical biotechnology company, reports that the previously...
Ritter Pharmaceuticals Reports Year End 2018 Financial Results and Provides Business Update
29 mars 2019 09h00 HE
|
Ritter Pharmaceuticals, Inc.
LOS ANGELES, March 29, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of therapeutic products that modulate the gut...
Ritter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance
05 mars 2019 08h30 HE
|
Ritter Pharmaceuticals, Inc.
Top-line Data Readout Expected in early Q4 2019 LOS ANGELES, March 05, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a...
Midatech Pharma US enrols first patient in Gelclair trial in stem cell transplant
08 juin 2018 02h00 HE
|
Midatech Pharma Plc
8 June 2018 Midatech Pharma PLC(“Midatech”, “Company” or “Group”) Midatech Pharma US enrols first patient in Gelclair® trial in stem cell transplant Patients now being enrolled at the...
Predictive Technology Group Appoints Dr. Gregory A. Prince to Its Scientific Advisory Board
17 janv. 2018 09h20 HE
|
PREDICTIVE TECHNOLOGY GROUP, INC.
SALT LAKE CITY, Jan. 17, 2018 (GLOBE NEWSWIRE) --
Predictive Technology Group, Inc. (OTC PINK:PRED), a leader in the use of data analytics for disease identification and subsequent...
Predictive Technology Group (PRED) Appoints John C. Nelson, M.D., M.P.H. to the Predictive Technology Group Scientific Advisory Board
11 janv. 2018 09h30 HE
|
PREDICTIVE TECHNOLOGY GROUP, INC.
SALT LAKE CITY, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTCPINK:PRED) announces that Dr. John C. Nelson, M.D., M.P.H. will join the Predictive Technology Group...